{
  "id": [
    "28160570"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "28160570"
  ],
  "pmcid": [
    "PMC5410286"
  ],
  "doi": [
    "10.18632/oncotarget.14981"
  ],
  "title": [
    "Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome."
  ],
  "authorString": [
    "Macanas-Pirard P, Broekhuizen R, González A, Oyanadel C, Ernst D, García P, Montecinos VP, Court F, Ocqueteau M, Ramirez P, Nervi B."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Macanas-Pirard P"
          ],
          "firstName": [
            "Patricia"
          ],
          "lastName": [
            "Macanas-Pirard"
          ],
          "initials": [
            "P"
          ],
          "affiliation": [
            "Department of Hematology and Oncology, UC-Center for Investigation in Translational Oncology (CITO), Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile."
          ]
        },
        {
          "fullName": [
            "Broekhuizen R"
          ],
          "firstName": [
            "Richard"
          ],
          "lastName": [
            "Broekhuizen"
          ],
          "initials": [
            "R"
          ],
          "affiliation": [
            "Millennium Institute on Immunology and Immunotherapy, Pontificia Universidad Católica de Chile, Santiago, Chile."
          ]
        },
        {
          "fullName": [
            "González A"
          ],
          "firstName": [
            "Alfonso"
          ],
          "lastName": [
            "González"
          ],
          "initials": [
            "A"
          ],
          "affiliation": [
            "Facultad de Medicina, Universidad San Sebastián, Center for Aging and Regeneration (CARE), Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile."
          ]
        },
        {
          "fullName": [
            "Oyanadel C"
          ],
          "firstName": [
            "Claudia"
          ],
          "lastName": [
            "Oyanadel"
          ],
          "initials": [
            "C"
          ],
          "affiliation": [
            "Facultad de Ciencia, Universidad San Sebastián, Fundación Ciencia y Vida, Santiago, Chile."
          ]
        },
        {
          "fullName": [
            "Ernst D"
          ],
          "firstName": [
            "Daniel"
          ],
          "lastName": [
            "Ernst"
          ],
          "initials": [
            "D"
          ],
          "affiliation": [
            "Department of Hematology and Oncology, UC-Center for Investigation in Translational Oncology (CITO), Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile."
          ]
        },
        {
          "fullName": [
            "García P"
          ],
          "firstName": [
            "Patricia"
          ],
          "lastName": [
            "García"
          ],
          "initials": [
            "P"
          ],
          "affiliation": [
            "Millennium Institute on Immunology and Immunotherapy, Pontificia Universidad Católica de Chile, Santiago, Chile."
          ]
        },
        {
          "fullName": [
            "Montecinos VP"
          ],
          "firstName": [
            "Viviana P"
          ],
          "lastName": [
            "Montecinos"
          ],
          "initials": [
            "VP"
          ],
          "affiliation": [
            "Department of Hematology and Oncology, UC-Center for Investigation in Translational Oncology (CITO), Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile."
          ]
        },
        {
          "fullName": [
            "Court F"
          ],
          "firstName": [
            "Felipe"
          ],
          "lastName": [
            "Court"
          ],
          "initials": [
            "F"
          ],
          "affiliation": [
            "Department of Physiology, Millennium Nucleus for Regenerative Biology, Faculty of Biology, Pontificia Universidad Católica de Chile, Santiago, Chile."
          ]
        },
        {
          "fullName": [
            "Ocqueteau M"
          ],
          "firstName": [
            "Mauricio"
          ],
          "lastName": [
            "Ocqueteau"
          ],
          "initials": [
            "M"
          ],
          "affiliation": [
            "Department of Hematology and Oncology, UC-Center for Investigation in Translational Oncology (CITO), Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile."
          ]
        },
        {
          "fullName": [
            "Ramirez P"
          ],
          "firstName": [
            "Pablo"
          ],
          "lastName": [
            "Ramirez"
          ],
          "initials": [
            "P"
          ],
          "affiliation": [
            "Institute of Medicine, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Región de los Ríos, Chile."
          ]
        },
        {
          "fullName": [
            "Nervi B"
          ],
          "firstName": [
            "Bruno"
          ],
          "lastName": [
            "Nervi"
          ],
          "initials": [
            "B"
          ],
          "affiliation": [
            "Millennium Institute on Immunology and Immunotherapy, Pontificia Universidad Católica de Chile, Santiago, Chile."
          ]
        }
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "14"
      ],
      "volume": [
        "8"
      ],
      "journalIssueId": [
        "2548899"
      ],
      "dateOfPublication": [
        "2017 Apr"
      ],
      "monthOfPublication": [
        "4"
      ],
      "yearOfPublication": [
        "2017"
      ],
      "printPublicationDate": [
        "2017-04-01"
      ],
      "journal": [
        {
          "title": [
            "Oncotarget"
          ],
          "ISOAbbreviation": [
            "Oncotarget"
          ],
          "medlineAbbreviation": [
            "Oncotarget"
          ],
          "NLMid": [
            "101532965"
          ],
          "ISSN": [
            "1949-2553"
          ],
          "ESSN": [
            "1949-2553"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2017"
  ],
  "pageInfo": [
    "23073-23086"
  ],
  "abstractText": [
    "The interaction between acute myeloid leukemia cells (AML) with the bone marrow stroma cells (BMSCs) determines a protective environment that favors tumor development and resistance to conventional chemotherapy. We showed that BMSCs secrete soluble factors that protect AML cells from Ara-C induced cytotoxicity. This leukemia chemoresistance is associated with a decrease in the equilibrative nucleoside transporter (ENT1) activity by inducing removal of ENT1 from the cell surface. Reduction of cell proliferation was also observed with activation of AKT and mTOR-dependent cell survival pathways, which may also contribute to the tumor chemoprotection. Analysis of primary BMSC cultures has demonstrated that AML patients with stroma capable to confer Ara-C resistance in vitro compared to AML patients without this stroma capacity were associated with a worse prognosis. The two year overall survival rate was 0% versus 80% respectively (p=0.0001). This is the first report of a chemoprotection mechanism based on the removal of a drug transporter from the cell surface and most importantly the first time that a stroma phenotype has correlated with prognostic outcome in cancer."
  ],
  "affiliation": [
    "Department of Hematology and Oncology, UC-Center for Investigation in Translational Oncology (CITO), Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile."
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "research-article",
        "Journal Article"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Bone Marrow Cells"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PA"
                  ],
                  "qualifierName": [
                    "pathology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Cell Line, Tumor"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Stromal Cells"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PA"
                  ],
                  "qualifierName": [
                    "pathology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Bone Marrow"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Equilibrative Nucleoside Transporter 1"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Cytarabine"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Drug Resistance, Neoplasm"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Leukemia, Myeloid, Acute"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PA"
                  ],
                  "qualifierName": [
                    "pathology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Patient Outcome Assessment"
          ]
        }
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Leukemia",
        "Biomarker",
        "Ent1",
        "Bone Marrow Stroma",
        "Cytarabine-resistance"
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "SLC29A1 protein, human"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Equilibrative Nucleoside Transporter 1"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Cytarabine"
          ],
          "registryNumber": [
            "04079A1RDZ"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC5410286?pdf=render"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC5410286"
          ]
        },
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.18632/oncotarget.14981"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "3"
  ],
  "hasReferences": [
    "N"
  ],
  "hasTextMinedTerms": [
    "N"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2017-09-27"
  ],
  "dateOfCreation": [
    "2017-02-04"
  ],
  "dateOfRevision": [
    "2017-09-27"
  ],
  "firstPublicationDate": [
    "2017-02-01"
  ]
}